CONMED Corporation (CNMD)
NYSE: CNMD · Real-Time Price · USD
35.52
+0.04 (0.11%)
At close: May 28, 2026, 4:00 PM EDT
35.52
0.00 (0.00%)
After-hours: May 28, 2026, 4:57 PM EDT
CONMED Revenue
CONMED had revenue of $317.05M in the quarter ending March 31, 2026, a decrease of -1.31%. This brings the company's revenue in the last twelve months to $1.37B, up 4.14% year-over-year. In the year 2025, CONMED had annual revenue of $1.37B with 5.18% growth.
Revenue (ttm)
$1.37B
Revenue Growth
+4.14%
P/S Ratio
0.79
Revenue / Employee
$351,414
Employees
3,900
Market Cap
1.07B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.37B | 67.70M | 5.18% |
| Dec 31, 2024 | 1.31B | 62.28M | 5.00% |
| Dec 31, 2023 | 1.24B | 199.27M | 19.06% |
| Dec 31, 2022 | 1.05B | 34.83M | 3.45% |
| Dec 31, 2021 | 1.01B | 148.18M | 17.18% |
| Dec 31, 2020 | 862.46M | -92.64M | -9.70% |
| Dec 31, 2019 | 955.10M | 95.46M | 11.11% |
| Dec 31, 2018 | 859.63M | 63.24M | 7.94% |
| Dec 31, 2017 | 796.39M | 32.87M | 4.31% |
| Dec 31, 2016 | 763.52M | 44.35M | 6.17% |
| Dec 31, 2015 | 719.17M | -20.89M | -2.82% |
| Dec 31, 2014 | 740.06M | -22.65M | -2.97% |
| Dec 31, 2013 | 762.70M | -4.44M | -0.58% |
| Dec 31, 2012 | 767.14M | 42.06M | 5.80% |
| Dec 31, 2011 | 725.08M | 11.35M | 1.59% |
| Dec 31, 2010 | 713.72M | 18.98M | 2.73% |
| Dec 31, 2009 | 694.74M | -47.44M | -6.39% |
| Dec 31, 2008 | 742.18M | 47.90M | 6.90% |
| Dec 31, 2007 | 694.29M | 47.48M | 7.34% |
| Dec 31, 2006 | 646.81M | 29.51M | 4.78% |
| Dec 31, 2005 | 617.31M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| QuidelOrtho | 2.66B |
| Enovis | 2.28B |
| Integra LifeSciences Holdings | 1.64B |
| Tandem Diabetes Care | 1.03B |
| Inspire Medical Systems | 915.25M |
| Alphatec Holdings | 787.08M |
| Avanos Medical | 715.90M |
| Artivion | 458.69M |
CNMD News
- 8 days ago - Conmed appoints Martin, Mirviss to its Board of Directors - TheFly
- 8 days ago - CONMED Corporation Appoints Celine Martin and Jeff Mirviss to its Board of Directors - Business Wire
- 10 days ago - CONMED Transcript: AGM 2026 - Transcripts
- 10 days ago - Conmed price target lowered to $40 from $52 at BofA - TheFly
- 4 weeks ago - Conmed price target lowered to $40 from $43 at JPMorgan - TheFly
- 4 weeks ago - Conmed reports Q1 EPS 89c, consensus 82c - TheFly
- 4 weeks ago - Conmed backs FY26 EPS view of $4.30-$4.45, consensus $4.45 - TheFly
- 4 weeks ago - CONMED Earnings Call Transcript: Q1 2026 - Transcripts